Treatment of Facial Cellulitis
For facial cellulitis, amoxicillin-clavulanate 875/125 mg twice daily orally for 5-7 days is the recommended first-line treatment, as it provides coverage against the most common causative organisms including beta-hemolytic streptococci and Staphylococcus aureus. 1, 2
Causative Organisms and Antibiotic Selection
Facial cellulitis is typically caused by:
- Beta-hemolytic Streptococcus (most common)
- Staphylococcus aureus (including MRSA in certain populations)
- Mixed flora in some cases
First-line Treatment:
Alternative Regimens (for penicillin allergic patients):
- Clindamycin 300-450 mg orally three times daily for 5-7 days 1, 3
- In areas with high MRSA prevalence: trimethoprim-sulfamethoxazole (160-800 mg twice daily) plus coverage for streptococci 1, 3
Special Considerations for Facial Cellulitis
Facial cellulitis requires special attention because:
- It involves a high-risk anatomical location (proximity to brain and eyes)
- May require more aggressive treatment than cellulitis at other sites
- Has potential for serious complications if inadequately treated
Risk Factors Requiring Broader Coverage:
- Prior MRSA exposure or high community prevalence
- Immunocompromised status
- Severe presentation
- Failure to improve within 48-72 hours on initial therapy 1, 2
Treatment Duration and Monitoring
- Standard duration: 5-7 days for uncomplicated facial cellulitis 1, 2
- Extended treatment (7-10 days) for:
- Severe infections
- Immunocompromised patients
- Slow clinical response 1
When to Consider IV Therapy:
- Rapidly progressing infection
- Systemic symptoms (fever, chills)
- Periorbital involvement
- Failure of oral therapy
- Immunocompromised host 2, 4
Diagnostic Considerations
- Blood cultures should be obtained in severe cases before starting antibiotics 1
- Culture any wound drainage if present to guide targeted therapy 1
- Consider rare causative organisms like Neisseria meningitidis in cases with bacteremia 5
Treatment Failure
If no improvement is seen within 48-72 hours, consider:
- Resistant organisms (particularly MRSA)
- Need for broader antimicrobial coverage
- Underlying conditions complicating treatment
- Possible deeper infection requiring surgical intervention 2, 3
Pitfalls to Avoid
- Failing to recognize the potential severity of facial cellulitis due to anatomic location
- Using antibiotics without adequate streptococcal coverage (e.g., trimethoprim-sulfamethoxazole alone)
- Not adjusting therapy when clinical improvement is not observed
- Missing underlying predisposing factors that may lead to recurrence
- Inadequate duration of therapy leading to relapse 1, 2, 3